Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2000
The overall objective of this study is to collect data relevant to the tolerability of Novantrone® therapy in patients with multiple sclerosis (MS) using dosing and monitoring recommendations specified in the package insert.
Epistemonikos ID: ab3fb0bed5bbbef3da4ed481612198166e7c122d
First added on: May 04, 2024